首页> 外文期刊>Southern Med Review >Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
【24h】

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

机译:通过多方利益相关者倡议促进透明度,问责制和获取:药品透明度联盟的经验教训

获取原文
       

摘要

Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges. Multi-stakeholder initiatives such as the Medicines Transparency Alliance (MeTA) may help overcome these barriers. Between 2008 and 2015, MeTA engaged stakeholders in the pharmaceutical sectors of seven countries (Ghana, Jordan, Kyrgyzstan, Peru, Philippines, Uganda, and Zambia) to promote access goals through greater transparency.
机译:扩大获得药品的障碍包括制药部门治理薄弱,缺乏透明度和问责制,对政治议程中社会服务的重视不足以及融资挑战。药品透明联盟(MeTA)等多方利益相关者的倡议可能有助于克服这些障碍。在2008年至2015年期间,MeTA与七个国家(加纳,约旦,吉尔吉斯斯坦,秘鲁,菲律宾,乌干达和赞比亚)的制药行业的利益相关方合作,通过提高透明度来促进获取目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号